In general, the potential use of DPP4 as a binding target (coreceptor) for SARS-CoV-2 may provide new insights into the pathogenesis of the virus and help develop monitoring and treatment strategies to address the challenges of COVID-19. The gene discussed is DPP4; the disease is COVID-19.